Cardiol Therapeutics Inc. (CRDL)

NASDAQ

$1.18

$+0.03

(+2.61%)

After-Hours

Cardiol Therapeutics Inc. (CRDL) Live Price Chart

Last updated: ⁦2026-10-21 20:51:00⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Cardiol Therapeutics Inc. (CRDL) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.18, with a market capitalization of $133.66M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.88 to $2.34. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$133.66M
Open	$1.15
Day's High	$4.96
Day's Low	$0.45
Previous Close	$1.15
Volume	592.99K
Average Volume	1.43M
P/E Ratio	--
52-Week High	$2.34
52-Week Low	$0.88
Dividend Yield	--
Earnings Date	--

Cardiol Therapeutics Inc. (CRDL) After-Hours Stock Price

Cardiol Therapeutics Inc. (CRDL) is trading at $1.18 in after-hours trading as of 2026-10-21 20:28:00, up 2.17% ($0.03) from the regular-session close of $1.15.

After-hours trading shows how investors are pricing CRDL after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

Cardiol Therapeutics Inc. (CRDL) 7-Day Stock Price Change

Over the past seven days, Cardiol Therapeutics Inc. (CRDL) moved from $1.18 to $1.18, representing a decline of 0.42% ($0.00).

The stock traded between $1.08 and $1.29 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 1.03 million shares, down versus the previous seven-day period, indicating lower trading activity.

CRDL 52-Week Price Position

Position in Range: 20.2%

52W Low$0.88

52W High$2.34

CRDL is currently trading at $1.18, placing it 20.2% of the way from its 52-week low of $0.88 to its 52-week high of $2.34. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cardiol Therapeutics Inc. (CRDL)?

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Cardiol Therapeutics Inc. Information

Employees	18
Exchange	NASDAQ
Company Website	https://www.cardiolrx.com

How to Buy Cardiol Therapeutics Inc. (CRDL) Stock on MEXC

Eligible investors can buy real shares of Cardiol Therapeutics Inc. (CRDL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CRDL and Place Your Order

Open the RealStocks trading page and search for CRDL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cardiol Therapeutics Inc. (CRDL) stock price today?

Cardiol Therapeutics Inc. (CRDL) is currently trading at $ 1.18, up 2.17% ($0.03) from the previous close of $ 1.15. Intraday prices update in real time during regular trading hours.

2.Is CRDL stock going up or down today?

As of 2026-10-21 20:28:00, CRDL is trading at $ 1.18, up 2.17% ($0.03) from its previous close of $ 1.15. The stock has traded between $ 0.45 and $ 4.96 during today’s regular session. Past price movements do not guarantee future results.

3.What is CRDL pre-market price?

As of 2026-10-21 20:28:00, CRDL is trading at $ 1.16 in pre-market trading, up 0.87% ($0.01) from the previous close of $ 1.15. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CRDL after-hours price?

As of 2026-10-21 20:28:00, CRDL is trading at $ 1.18 in after-hours trading, up 2.17% ($0.03) from the regular-session close of $ 1.15. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CRDL stock trading now?

CRDL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CRDL sit relative to its 52-week high and low?

Over the past 52 weeks, CRDL has traded between a low of $ 0.88 and a high of $ 2.34. At $ 1.18, the stock is positioned 20.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cardiol Therapeutics Inc. in?

Cardiol Therapeutics Inc. (CRDL) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cardiol Therapeutics Inc.'s market capitalization and where is it listed?

Cardiol Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 133.66M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CRDL valued in terms of P/E ratio and EPS?

CRDL trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cardiol Therapeutics Inc. pay a dividend?

Cardiol Therapeutics Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.